Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06f590664a23b767d17ac071047cf9fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe3b944ac67d05923f486056d827ef81 |
publicationDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013137584-A1 |
titleOfInvention |
Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies |
abstract |
The present invention provides methods of diagnosing a cancer or providing a prognosis for a cancer by analyzing the level of expression of a marker that is a downstream target of N-cadherin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9334500-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015094225-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111647598-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107338320-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2705251-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014335106-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2715643-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2716054-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020093026-A1 |
priorityDate |
2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |